A study involving scientists from the University of Leicester has established a link between hypoglycaemia and increased risk of cardiovascular events and mortality in patients with diabetes.
Biotronik announced the first enrollments in its prospective, multi-center, international Reduce-TE Pilot study (Reduction of AF Ablation Induced Thrombo-Embolic Incidence).
The U.S. Food and Drug Administration (FDA) has granted a humanitarian device exemption for the CVRx Inc. Barostim neo Legacy System.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Women who have breast cancer on their left side present a particular challenge to radiation oncologists. Studies have shown that the risk of heart disease is higher in this group of women after radiation treatment because it can be difficult to ensure that a sufficient dose of radiation is delivered to the left breast while adequately shielding the heart from exposure. New research shows a woman who holds her breath during radiation pulses can greatly reduce radiation exposure to the heart.
The American Society of Nuclear Cardiology (ASNC) has announced the launch of the first cardiovascular nuclear imaging data registry, ImageGuide.
Direct Flow Medical Inc. announced the closing of a new round of financing for the company totaling $32 million.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Bellerophon Therapeutics LLC announced that it has completed enrollment of its PRESERVATION I clinical trial of Bioabsorbable Cardiac Matrix (BCM), an investigational implantable medical device being studied for the prevention of congestive heart failure following an acute myocardial infarction (AMI). The procedure has been completed in 303 patients at almost 90 clinical sites in Australia, Europe, Israel and North America. The company expects to report top line results in mid-2015, following a six-month follow-up period for all patients.
Supplementing written heart screening guidelines with telephone counseling from specially trained nurses more than doubled the likelihood that adult survivors of childhood cancer received recommended heart checks, according to results from the Childhood Cancer Survivor Study (CCSS). St. Jude Children's Research Hospital investigators led the research, whose findings appear in the current issue of the Journal of Clinical Oncology.
ImaCor Inc. will be showcasing for the first time Zura EVO1, its all-in-one platform for advanced hemodynamic management, at three annual scientific meetings.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Non-contrast enhanced MR angiography (MRA) techniques have attracted interest in the medical community for diagnosing renal artery stenosis, as it eliminates the need for contrast agents used with computed tomography angiography (CTA).
The Society of Interventional Radiology (SIR) unveiled a new brand for the society and its research organization, the SIR Foundation.
At Medanta Hospital in Gurgaon, India, five EchoBox devices were connected to five GE Vivid ultrasound systems, streaming live echo images over the Web to experienced sonographers located in the United States. The sonographers were members of the American Society of Echocardiography, and were able to view the images in real-time as they were being scanned. This novel approach enabled remote imaging training for eight Indian physicians during live patient examinations.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Oxford Performance Materials Inc. (OPM) announced the commencement of an extensive joint research program with Yale University to develop innovative and cost-effective 3-D printed biomedical technologies and applications.
X-ray phase tomography is an imaging technique that uses penetrating X-rays to create volumetric views through "slices" or sections of soft biological tissues, such as tumors, and it offers strongly enhanced contrast compared to conventional CT scans.
The OptoWire and OptoMonitor are Opsens’ products for FFR measurements to optimize the diagnosis and guide the therapy in patients with coronary heart disease.